What is Rigel Pharmaceuticals's investment proceeds?

Rigel Pharmaceuticals (RIGL) reported investment proceeds of $15.95M in Q1 2026.

How has Rigel Pharmaceuticals's investment proceeds changed year-over-year?

Rigel Pharmaceuticals's investment proceeds increased by 43.6% year-over-year, from $11.1M to $15.95M.

What is the long-term trend for Rigel Pharmaceuticals's investment proceeds?

Over 4 years (2021 to 2025), Rigel Pharmaceuticals's investment proceeds has grown at a -0.4% compound annual growth rate (CAGR), from $62.05M to $61.13M.

What does investment proceeds mean?

Cash received from sales, maturities, and redemptions of investment securities across all categories.

Rigel Pharmaceuticals RIGL Investment Proceeds

Investment Proceeds at other companies

Agios PharmaceuticalsAGIO

$290.26M+0.7%

Zevra Therapeutics, Inc.ZVRA

$93.97M+422%

Gyre Therapeutics, Inc.GYRE

$10.07M-10.0%

Theravance BiopharmaTBPH

$96M+194%

Opko HealthOPK

$0-100%

Ionis PharmaceuticalsIONS

$752.82M+52.2%

Other financials

Income statement

See full

Revenue$58.8M+10.3%

Gross profit$54.2M+10.8%

Operating income$11.9M-7.0%

Net income$8.7M-24.4%

EPS (diluted)$0.44-30.2%

Balance sheet

See full

Cash & equivalents$24.5M-46.6%

Total debt$68.4M+5,079%

Total equity$399.9M+2,054%

Total assets$504.6M+187%

Cash flow

See full

Operating cash flow$2.7M+405%

CapEx$73.0K—

Free cash flow-$22.0M—

Valuation

See full

Market cap$684.39M+102%

Enterprise value$728.29M+148%

P/E1.9×-7.2×

P/S2.3×+0.6×

Profitability

See full

Gross margin93.4%+3.7pp

Operating margin41.6%+19.9pp

Net margin121.5%+103pp

FCF margin-61.7%—

Returns & leverage

See full

Return on equity174.1%—

Debt / equity0.2×+0.1×

Current ratio2.6×+0.4×

Where this comes from

Reported directly by Rigel Pharmaceuticals in its filing.

Tagged under the XBRL concept us-gaap:ProceedsFromMaturitiesPrepaymentsAndCallsOfShorttermInvestments.

The official record: Rigel Pharmaceuticals’s 10-Q, filed May 5, 2026, on SEC EDGAR. View the filing →

Ask your AI about Rigel Pharmaceuticals's investment proceeds.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI

Claude

Questions, answered.

What is Rigel Pharmaceuticals's investment proceeds?: Rigel Pharmaceuticals (RIGL) reported investment proceeds of $15.95M in Q1 2026.
How has Rigel Pharmaceuticals's investment proceeds changed year-over-year?: Rigel Pharmaceuticals's investment proceeds increased by 43.6% year-over-year, from $11.1M to $15.95M.
What is the long-term trend for Rigel Pharmaceuticals's investment proceeds?: Over 4 years (2021 to 2025), Rigel Pharmaceuticals's investment proceeds has grown at a -0.4% compound annual growth rate (CAGR), from $62.05M to $61.13M.
What does investment proceeds mean?: Cash received from sales, maturities, and redemptions of investment securities across all categories.